Resources

This publication provides data about use of pharmacy programs funded under the Seventh Community Pharmacy Agreements (7CPAs)

This publication provides data about use of rural support and Aboriginal and Torres Strait Islander pharmacy programs funded under the Seventh Community Pharmacy Agreement (7CPAs).

Use this form to help transition a patient’s care to a new physician, where there are no other changes to their treatment or eligibility for the Life Saving Drugs Program (LDSP).

This collection contains meeting summaries from the Education and Training Expert Advisory Group.

This document contains the terms of reference for the Intellectual Disability Health Education and Training Expert Advisory Group.

This document summarises the discussion and outcomes of the fifth meeting of the Education and Training Expert Advisory Group (EAG), held on 9 November 2022.

This document summarises the discussion and outcomes of the fourth meeting of the Education and Training Expert Advisory Group (EAG), held on 16 June 2022.

This document summarises the discussion and outcomes of the third meeting of the Education and Training Expert Advisory Group (EAG), held on 13 April 2022.

This document summarises the discussion and outcomes of the second meeting of the Education and Training Expert Advisory Group (EAG), held on 23 February 2022.

This document summarises the discussion and outcomes of the first meeting of the Education and Training Expert Advisory Group (EAG), held on 8 December 2021.

Treating physicians use this application form to apply for a patient to access LSDP medication for Fabry disease for the first time, or after a break.

This report provides a framework and proposes options for governance that would align the Prostheses List processes with those of other health technology assessment processes within the Government. It was developed by Adelaide Health Technology Assessment, under the Prostheses List Reform program.

This report outlines the pre-listing assessment framework and governance structure for the Prostheses List. It also addresses Ernst & Young, and Adelaide Health Technology Assessment options and recommendations.

This review provides options and recommendations for the future governance of the Prostheses List. It was developed by Ernst & Young under the Department’s Prostheses List Reform program.

This report is of gifts given to officers of the Department of Health that are valued over $100, as at 31 December 2022.

This collection presents reports of gifts given to officers of the Department of Health that are valued over $100.

The experiences of older people in residential aged care provides vital insights into the quality of care and services they receive. Residents’ Experience Survey (formerly Consumer Experience Interviews) results provide residential aged care homes with useful data to identify areas for improvement.

This guidance document outlines our process and associated timelines to consider medicines seeking funding through the LSDP. It helps sponsors to prepare an application to make an ultra-rare disease medicine available on the LSDP.

This fact sheet provides information to help support the correct billing of Medicare Benefits Schedule Items (MBS) 18222 and 18225 for regional or field nerve blocks.

Health professionals can print this fact sheet and give it to patients who are starting treatment under the Life Saving Drugs Program.

This fact sheet gives answers to common questions about the role of pharmacies and authorised persons in managing Life Saving Drugs Program (LSDP) medicines.

This fact sheet gives answers to common questions about the role of treating physicians in prescribing Life Saving Drugs Program (LSDP) medicines.

This community service announcement explains what Aboriginal and Torres Strait Islander peoples can do to take care of their mental health and wellbeing during the coronavirus outbreak.